Research progress on the incidence and economic burden of herpes zoster disease in immunocompromised population.
10.3760/cma.j.cn112150-20210729-00728
- Author:
Ying Ying YANG
1
;
Chuan Xi FU
1
Author Information
1. Institute of Infectious Disease and Vaccine, School of Public Health, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Publication Type:Review
- MeSH:
Financial Stress;
Herpes Zoster/epidemiology*;
Herpesvirus 3, Human;
Humans;
Incidence;
Neuralgia, Postherpetic/prevention & control*;
Quality of Life
- From:
Chinese Journal of Preventive Medicine
2022;56(3):386-390
- CountryChina
- Language:Chinese
-
Abstract:
With the increase of age or the impairment of immune function, the specific cellular immune level against varicella zoster virus (VZV) in the body decreases, and the latent VZV in the ganglion can be reactivated to cause herpes zoster (HZ). HZ and its main complication postherpetic neuralgia (PHN) can seriously affect the quality of life of patients. The immunocompromised (IC) population is more prone to HZ than the immunocompetent population due to diseases and therapeutic drugs. This paper reviews the incidence, risk factor and economic burden of HZ in IC population with special health status, to provide ideas for research and adjustment of immunization strategies in the future.
